Ancient herb meets modern painkiller in battle against chronic prostatitis pain
NCT ID NCT06159114
First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time
Summary
This trial tests whether Ningmitai, a traditional Chinese medicine used for urinary issues, can reduce pelvic pain in men with chronic prostatitis. About 240 men aged 18-60 with long-term pelvic discomfort will receive either Ningmitai alone, the painkiller celecoxib alone, or both for 6 weeks. The goal is to see if the herbal capsule, alone or combined, outperforms celecoxib in easing pain.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ningmitai capsule, a traditional Chinese medicine, alone or combined with celecoxib
- What this could lead to
- If effective, Ningmitai could offer a new option for managing chronic pelvic pain in men with prostatitis, possibly reducing reliance on standard painkillers.
- What could go wrong
- This is a Phase 4 trial with 240 participants, so results may not apply broadly. Ningmitai is a traditional remedy with limited modern evidence, and celecoxib carries risks like stomach bleeding.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PROSTATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.